Solventum Q3 Adjusted EPS USD 1.45 Vs. IBES Estimate USD 1.35

By Reuters News

Nov 05 (Reuters) - Solventum Q3 sales USD 1,949 million vs. IBES estimate USD 1,935 million.

  • Q3 EPS USD -0.07
  • Q3 net income USD -12 million
  • outlook FY adjusted EPS USD 7.2-7.3 vs. IBES estimate USD 7.18

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk